Thalidomide-O-PEG5-Acid CAS:2353563-48-9 is a type of small molecule drug that is used in the treatment of certain types of cancer and inflammatory diseases. It is composed of several functional groups, including a thalidomide group, a polyethylene glycol (PEG) spacer, and a carboxylic acid group.
Thalidomide is a type of immunomodulatory drug that has been shown to be effective in treating certain types of cancer, such as multiple myeloma and myelodysplastic syndromes, as well as inflammatory diseases such as rheumatoid arthritis and Crohn’s disease. The PEG spacer in Thalidomide-O-PEG5-Acid is used to improve the solubility and stability of the drug in solution, allowing it to be more easily administered to patients. The carboxylic acid group is important for the chemical reactivity and solubility of the compound.
In terms of its mechanism of action, Thalidomide-O-PEG5-Acid works by modulating the activity of certain immune cells in the body, particularly T cells and natural killer cells. By enhancing the activity of these cells, Thalidomide-O-PEG5-Acid can help to boost the body’s immune response to cancer cells and reduce inflammation, leading to improved outcomes for patients with cancer and inflammatory diseases.
Thalidomide-O-PEG5-Acid represents an important advance in the treatment of cancer and inflammatory diseases. By targeting specific immune cells and modulating their activity, this drug has shown significant promise in improving outcomes for patients and extending their lives.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
